Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2004 Apr;13(2):75–88. doi: 10.1080/09629350410001688477

The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion.

Marina G Smirnova 1, John P Birchall 1, Jeffrey P Pearson 1
PMCID: PMC1781541  PMID: 15203548

Abstract

Inflammation in the middle ear mucosa, which can be provoked by different primary factors such as bacterial and viral infection, local allergic reactions and reflux, is the crucial event in the pathogenesis of otitis media with effusion (OME). Unresolved acute inflammatory responses or defective immunoregulation of middle inflammation can promote chronic inflammatory processes and stimulate the chronic condition of OME. Cytokines are the central molecular regulators of middle ear inflammation and can switch the acute phase of inflammation in the chronic stage and induce molecular-pathological processes leading to the histopathological changes accompanying OME. In this review we present cytokines identified in otitis media, immunoregulatory [interleukin (IL)-2, IL-10, transforming growth factor-beta]) and allergy associated (IL-4, IL-5, granulocyte-macrophage colony-stimulating factor), as crucial molecular regulators, responsible for chronic inflammation in the middle ear and the chronic condition of OME.

Full Text

The Full Text of this article is available as a PDF (778.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akagawa K. S., Takasuka N., Nozaki Y., Komuro I., Azuma M., Ueda M., Naito M., Takahashi K. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood. 1996 Nov 15;88(10):4029–4039. [PubMed] [Google Scholar]
  2. Aström K., Magnusson C. G., Papatziamos G., Hemlin C., Scheynius A., van der Ploeg I. Analysis of epsilon germline transcripts and IL-4 mRNA expression in the adenoids suggests local IgE switching. Allergy. 2000 Nov;55(11):1049–1055. doi: 10.1034/j.1398-9995.2000.00703.x. [DOI] [PubMed] [Google Scholar]
  3. Baccarini M., Schwinzer R., Lohmann-Matthes M. L. Effect of human recombinant IL-2 on murine macrophage precursors. Involvement of a receptor distinct from the p55 (Tac) protein. J Immunol. 1989 Jan 1;142(1):118–125. [PubMed] [Google Scholar]
  4. Baldwin G. C. The biology of granulocyte-macrophage colony-stimulating factor: effects on hematopoietic and nonhematopoietic cells. Dev Biol. 1992 Jun;151(2):352–367. doi: 10.1016/0012-1606(92)90175-g. [DOI] [PubMed] [Google Scholar]
  5. Bergamini A., Bolacchi F., Bongiovanni B., Cepparulo M., Ventura L., Capozzi M., Sarrecchia C., Rocchi G. Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. Immunology. 2000 Oct;101(2):254–261. doi: 10.1046/j.1365-2567.2000.00117.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bernstein J. M., Ballow M., Xiang S., O'Neil K. Th1/Th2 cytokine profiles in the nasopharyngeal lymphoid tissues of children with recurrent otitis media. Ann Otol Rhinol Laryngol. 1998 Jan;107(1):22–27. doi: 10.1177/000348949810700105. [DOI] [PubMed] [Google Scholar]
  7. Bernstein J. M., Doyle W. J. Role of IgE-mediated hypersensitivity in otitis media with effusion: pathophysiologic considerations. Ann Otol Rhinol Laryngol Suppl. 1994 May;163:15–19. doi: 10.1177/00034894941030s505. [DOI] [PubMed] [Google Scholar]
  8. Bernstein J. M., Lee J., Conboy K., Ellis E., Li P. Further observations on the role of IgE-mediated hypersensitivity in recurrent otitis media with effusion. Otolaryngol Head Neck Surg. 1985 Oct;93(5):611–615. doi: 10.1177/019459988509300508. [DOI] [PubMed] [Google Scholar]
  9. Bernstein J. M., Park B. H. Defective immunoregulation in children with chronic otitis media with effusion. Otolaryngol Head Neck Surg. 1986 Mar;94(3):334–339. doi: 10.1177/019459988609400313. [DOI] [PubMed] [Google Scholar]
  10. Bernstein J. M., Rich G. A., Odziemiec C., Ballow M. Are thymus-derived lymphocytes (T cells) defective in the nasopharyngeal and palatine tonsils of children? Otolaryngol Head Neck Surg. 1993 Oct;109(4):693–700. doi: 10.1177/019459989310900410. [DOI] [PubMed] [Google Scholar]
  11. Bernstein J. M. Role of allergy in eustachian tube blockage and otitis media with effusion: a review. Otolaryngol Head Neck Surg. 1996 Apr;114(4):562–568. doi: 10.1016/S0194-59989670247-4. [DOI] [PubMed] [Google Scholar]
  12. Bikhazi P., Ryan A. F. Expression of immunoregulatory cytokines during acute and chronic middle ear immune response. Laryngoscope. 1995 Jun;105(6):629–634. doi: 10.1288/00005537-199506000-00013. [DOI] [PubMed] [Google Scholar]
  13. Bluestone C. D. Role of surgery for otitis media in the era of resistant bacteria. Pediatr Infect Dis J. 1998 Nov;17(11):1090–1100. doi: 10.1097/00006454-199811000-00040. [DOI] [PubMed] [Google Scholar]
  14. Boedts D., De Groote G., Van Vuchelen J. Atopic allergy and otitis media with effusion. Acta Otolaryngol Suppl. 1984;414:108–114. doi: 10.3109/00016488409122890. [DOI] [PubMed] [Google Scholar]
  15. Brooks E. G., Schmalstieg F. C., Wirt D. P., Rosenblatt H. M., Adkins L. T., Lookingbill D. P., Rudloff H. E., Rakusan T. A., Goldman A. S. A novel X-linked combined immunodeficiency disease. J Clin Invest. 1990 Nov;86(5):1623–1631. doi: 10.1172/JCI114884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Brown M. A., Hural J. Functions of IL-4 and control of its expression. Crit Rev Immunol. 1997;17(1):1–32. doi: 10.1615/critrevimmunol.v17.i1.10. [DOI] [PubMed] [Google Scholar]
  17. Bundo J., Watanabe N., Yoshida K., Mogi G. Study on adhesion factors in lymphocyte migration to the middle ear mucosa. Ann Otol Rhinol Laryngol. 1996 Oct;105(10):795–803. doi: 10.1177/000348949610501007. [DOI] [PubMed] [Google Scholar]
  18. Carrie S., Hutton D. A., Birchall J. P., Green G. G., Pearson J. P. Otitis media with effusion: components which contribute to the viscous properties. Acta Otolaryngol. 1992;112(3):504–511. doi: 10.3109/00016489209137432. [DOI] [PubMed] [Google Scholar]
  19. Catanzaro A., Ryan A., Batcher S., Wasserman S. I. The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs. Laryngoscope. 1991 Mar;101(3):271–275. doi: 10.1288/00005537-199103000-00008. [DOI] [PubMed] [Google Scholar]
  20. Chung Myung-Hyun, Choi Jae Young, Lee Won-Sang, Kim Hee-Nam, Yoon Joo-Heon. Compositional difference in middle ear effusion: mucous versus serous. Laryngoscope. 2002 Jan;112(1):152–155. doi: 10.1097/00005537-200201000-00027. [DOI] [PubMed] [Google Scholar]
  21. Cooter M. S., Eisma R. J., Burleson J. A., Leonard G., Lafreniere D., Kreutzer D. L. Transforming growth factor-beta expression in otitis media with effusion. Laryngoscope. 1998 Jul;108(7):1066–1070. doi: 10.1097/00005537-199807000-00021. [DOI] [PubMed] [Google Scholar]
  22. D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993 Sep 1;178(3):1041–1048. doi: 10.1084/jem.178.3.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Dabbagh K., Takeyama K., Lee H. M., Ueki I. F., Lausier J. A., Nadel J. A. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol. 1999 May 15;162(10):6233–6237. [PubMed] [Google Scholar]
  24. Dagan R. Clinical significance of resistant organisms in otitis media. Pediatr Infect Dis J. 2000 Apr;19(4):378–382. doi: 10.1097/00006454-200004000-00033. [DOI] [PubMed] [Google Scholar]
  25. Dayer J. M., Burger D. Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Netw. 1994 Nov-Dec;5(6):563–571. [PubMed] [Google Scholar]
  26. Defrance T., Vanbervliet B., Brière F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med. 1992 Mar 1;175(3):671–682. doi: 10.1084/jem.175.3.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dugast C., Gaudin A., Toujas L. Generation of multinucleated giant cells by culture of monocyte-derived macrophages with IL-4. J Leukoc Biol. 1997 Apr;61(4):517–521. doi: 10.1002/jlb.61.4.517. [DOI] [PubMed] [Google Scholar]
  28. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991 Dec 1;147(11):3815–3822. [PubMed] [Google Scholar]
  29. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991 May 15;146(10):3444–3451. [PubMed] [Google Scholar]
  30. FitzGerald J. E., Green G. G., Birchall J. P., Pearson J. P. Rheologic studies on middle ear effusions and their mucus glycoproteins. Arch Otolaryngol Head Neck Surg. 1989 Apr;115(4):462–468. doi: 10.1001/archotol.1989.01860280060018. [DOI] [PubMed] [Google Scholar]
  31. Furukawa M., Kubo N., Yamashita T. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions. Laryngoscope. 1995 Feb;105(2):188–191. doi: 10.1288/00005537-199502000-00015. [DOI] [PubMed] [Google Scholar]
  32. Gloddek B., Lamm K., Haslov K. Influence of middle ear immune response on the immunological state and function of the inner ear. Laryngoscope. 1992 Feb;102(2):177–181. doi: 10.1288/00005537-199202000-00013. [DOI] [PubMed] [Google Scholar]
  33. Goycoolea M. V. Gland formation in otitis media. An ultrastructural study in humans. Acta Otolaryngol. 2001 Jan;121(2):182–184. doi: 10.1080/000164801300043406. [DOI] [PubMed] [Google Scholar]
  34. Harrison H., Fixsen A., Vickers A. A randomized comparison of homoeopathic and standard care for the treatment of glue ear in children. Complement Ther Med. 1999 Sep;7(3):132–135. doi: 10.1016/s0965-2299(99)80120-4. [DOI] [PubMed] [Google Scholar]
  35. Hart P. H., Vitti G. F., Burgess D. R., Whitty G. A., Piccoli D. S., Hamilton J. A. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci U S A. 1989 May;86(10):3803–3807. doi: 10.1073/pnas.86.10.3803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Hebda P. A., Alper C. M., Doyle W. J., Burckart G. J., Diven W. F., Zeevi A. Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol. 1998 Jun;107(6):501–507. doi: 10.1177/000348949810700608. [DOI] [PubMed] [Google Scholar]
  37. Hebda Patricia A., Piltcher Otavio B., Swarts J. Douglas, Alper Cuneyt M., Zeevi Adriana, Doyle William J. Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection. Laryngoscope. 2002 Sep;112(9):1657–1662. doi: 10.1097/00005537-200209000-00024. [DOI] [PubMed] [Google Scholar]
  38. Himi T., Kamimura M., Kataura A., Imai K. Quantitative analysis of soluble cell adhesion molecules in otitis media with effusion. Acta Otolaryngol. 1994 May;114(3):285–288. doi: 10.3109/00016489409126057. [DOI] [PubMed] [Google Scholar]
  39. Himi T., Suzuki T., Kodama H., Takezawa H., Kataura A. Immunologic characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl. 1992 Oct;157:21–25. doi: 10.1177/0003489492101s1006. [DOI] [PubMed] [Google Scholar]
  40. Hirai K., Miyamasu M., Takaishi T., Morita Y. Regulation of the function of eosinophils and basophils. Crit Rev Immunol. 1997;17(3-4):325–352. doi: 10.1615/critrevimmunol.v17.i3-4.40. [DOI] [PubMed] [Google Scholar]
  41. Ho A. S., Moore K. W. Interleukin-10 and its receptor. Ther Immunol. 1994 Jun;1(3):173–185. [PubMed] [Google Scholar]
  42. Hogan S. P., Foster P. S. Cellular and molecular mechanisms involved in the regulation of eosinophil trafficking in vivo. Med Res Rev. 1996 Sep;16(5):407–432. doi: 10.1002/(SICI)1098-1128(199609)16:5<407::AID-MED2>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  43. Horohov D. W., Crim J. A., Smith P. L., Siegel J. P. IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J Immunol. 1988 Dec 15;141(12):4217–4223. [PubMed] [Google Scholar]
  44. Hutton D. A., Fogg F. J., Kubba H., Birchall J. P., Pearson J. P. Heterogeneity in the protein cores of mucins isolated from human middle ear effusions: evidence for expression of different mucin gene products. Glycoconj J. 1998 Mar;15(3):283–291. doi: 10.1023/a:1006901213526. [DOI] [PubMed] [Google Scholar]
  45. Hutton D. A., Fogg F. J., Murty G., Birchall J. P., Pearson J. P. Preliminary characterization of mucin from effusions of cleft palate patients. Otolaryngol Head Neck Surg. 1993 Dec;109(6):1000–1006. doi: 10.1177/019459989310900605. [DOI] [PubMed] [Google Scholar]
  46. Hutton D. A., Guo L., Birchall J. P., Severn T. L., Pearson J. P. MUC5B expression in middle ear mucosal glands. Biochem Soc Trans. 1998 May;26(2):S117–S117. doi: 10.1042/bst026s117. [DOI] [PubMed] [Google Scholar]
  47. Jacobs J., Springer D. A., Crothers D. Homeopathic treatment of acute otitis media in children: a preliminary randomized placebo-controlled trial. Pediatr Infect Dis J. 2001 Feb;20(2):177–183. doi: 10.1097/00006454-200102000-00012. [DOI] [PubMed] [Google Scholar]
  48. Jang Chul-Ho, Kim Young-Ho. Characterization of cytokines present in pediatric otitis media with effusion: comparison of allergy positive and negative. Int J Pediatr Otorhinolaryngol. 2002 Oct 21;66(1):37–40. doi: 10.1016/s0165-5876(02)00185-4. [DOI] [PubMed] [Google Scholar]
  49. Jelinek D. F., Lipsky P. E. Regulation of human B lymphocyte activation, proliferation, and differentiation. Adv Immunol. 1987;40:1–59. doi: 10.1016/s0065-2776(08)60237-0. [DOI] [PubMed] [Google Scholar]
  50. Jeong Hyun-Ja, Hong Seung-Heon, Kim Sung-Chul, Park Eun-Jeong, Jang Chul-Ho, Kim Kyung-Suk, Kim Hyung-Min. Effects of Allergina on the treatment of otitis media with effusions. Inflammation. 2002 Apr;26(2):89–95. doi: 10.1023/a:1014888328482. [DOI] [PubMed] [Google Scholar]
  51. Jones E. A., Jr, Thomas L. R., Davis N. C. The significance of secretory IgA in middle ear fluid. Ann Allergy. 1979 Apr;42(4):236–240. [PubMed] [Google Scholar]
  52. Jono Hirofumi, Xu Haidong, Kai Hirofumi, Lim David J., Kim Young S., Feng Xin-Hua, Li Jian-Dong. Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK. J Biol Chem. 2003 May 6;278(30):27811–27819. doi: 10.1074/jbc.M301773200. [DOI] [PubMed] [Google Scholar]
  53. Jung T. T., Juhn S. K. Prostaglandins and other arachidonic acid metabolites in the middle ear fluids. Auris Nasus Larynx. 1985;12 (Suppl 1):S148–S150. doi: 10.1016/s0385-8146(85)80130-9. [DOI] [PubMed] [Google Scholar]
  54. Jung T. T. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope. 1988 Sep;98(9):980–993. doi: 10.1288/00005537-198809000-00013. [DOI] [PubMed] [Google Scholar]
  55. Jyonouchi H., Sun S., Le H., Rimell F. L. Evidence of dysregulated cytokine production by sinus lavage and peripheral blood mononuclear cells in patients with treatment-resistant chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2001 Dec;127(12):1488–1494. doi: 10.1001/archotol.127.12.1488. [DOI] [PubMed] [Google Scholar]
  56. Kawano H., Paparella M. M., Ho S. B., Schachern P. A., Morizono N., Le C. T., Lin J. Identification of MUC5B mucin gene in human middle ear with chronic otitis media. Laryngoscope. 2000 Apr;110(4):668–673. doi: 10.1097/00005537-200004000-00024. [DOI] [PubMed] [Google Scholar]
  57. Kiliç Rahmi, Safak Mustafa A., Ozdek Ali, Gömen Hakan, Kiliç Dilek, Samim Erdal. Effect of 23 valent pneumococcal polysaccharide and Haemophilus influenza conjugated vaccines on the clinical course of otitis media with effusion. Laryngoscope. 2002 Nov;112(11):2042–2045. doi: 10.1097/00005537-200211000-00024. [DOI] [PubMed] [Google Scholar]
  58. Kita H., Himi T. Cytokine and chemokine induction using cell wall component and toxin derived from gram-positive bacteria in the rat middle ear. Acta Otolaryngol. 1999;119(4):446–452. doi: 10.1080/00016489950180973. [DOI] [PubMed] [Google Scholar]
  59. Koike M., Takatsu K. IL-5 and its receptor: which role do they play in the immune response? Int Arch Allergy Immunol. 1994 May;104(1):1–9. doi: 10.1159/000236702. [DOI] [PubMed] [Google Scholar]
  60. Kubo T., Anniko M., Stenqvist M., Hsu W. Interleukin-2 affects cochlear function gradually but reversibly. ORL J Otorhinolaryngol Relat Spec. 1998 Sep-Oct;60(5):272–277. doi: 10.1159/000027609. [DOI] [PubMed] [Google Scholar]
  61. Kurono Y., Suzuki M., Mogi G., Yamamoto M., Fujihashi K., McGhee J. R., Kiyono H. Effects of intranasal immunization on protective immunity against otitis media. Int J Pediatr Otorhinolaryngol. 1999 Oct 5;49 (Suppl 1):S227–S229. doi: 10.1016/s0165-5876(99)00165-2. [DOI] [PubMed] [Google Scholar]
  62. Lang R. W., Liu Y. S., Lim D. J., Birck H. G. Antimicrobial factors and bacterial correlation in chronic otitis media with effusion. Ann Otol Rhinol Laryngol. 1976 Mar-Apr;85(2 Suppl 25 Pt 2):145–151. doi: 10.1177/00034894760850S227. [DOI] [PubMed] [Google Scholar]
  63. Letterio J. J., Roberts A. B. Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998;16:137–161. doi: 10.1146/annurev.immunol.16.1.137. [DOI] [PubMed] [Google Scholar]
  64. Lewis D. M., Schram J. L., Birck H. G., Lim D. J. Antibody activity in otitis media with effusion. Ann Otol Rhinol Laryngol. 1979 May-Jun;88(3 Pt 1):392–396. doi: 10.1177/000348947908800317. [DOI] [PubMed] [Google Scholar]
  65. Lewis D. M., Schram J. L., Lim D. J., Birck H. G., Gleich G. Immunoglobulin E in chronic middle ear effusions: conmparison of RIST, PRIST, and RIA techniques. Ann Otol Rhinol Laryngol. 1978 Mar-Apr;87(2 Pt 1):197–201. doi: 10.1177/000348947808700209. [DOI] [PubMed] [Google Scholar]
  66. Liederman E. M., Post J. C., Aul J. J., Sirko D. A., White G. J., Buchman C. A., Ehrlich G. D. Analysis of adult otitis media: polymerase chain reaction versus culture for bacteria and viruses. Ann Otol Rhinol Laryngol. 1998 Jan;107(1):10–16. doi: 10.1177/000348949810700103. [DOI] [PubMed] [Google Scholar]
  67. Lim D. J., Liu Y. S., Schram J., Birck H. G. Immunoglobulin E in chronic middle ear effusions. Ann Otol Rhinol Laryngol. 1976 Mar-Apr;85(2 Suppl 25 Pt 2):117–123. doi: 10.1177/00034894760850S222. [DOI] [PubMed] [Google Scholar]
  68. Linder T. E., Marder H. P., Munzinger J. Role of adenoids in the pathogenesis of otitis media: a bacteriologic and immunohistochemical analysis. Ann Otol Rhinol Laryngol. 1997 Aug;106(8):619–623. doi: 10.1177/000348949710600801. [DOI] [PubMed] [Google Scholar]
  69. Liu Y. S., Lim D. J., Lang R. W., Birck H. G. Chronic middle ear effusions. Immunochemical and bacteriological investigations. Arch Otolaryngol. 1975 May;101(5):278–286. doi: 10.1001/archotol.1975.00780340010003. [DOI] [PubMed] [Google Scholar]
  70. Malkovský M., Loveland B., North M., Asherson G. L., Gao L., Ward P., Fiers W. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature. 1987 Jan 15;325(6101):262–265. doi: 10.1038/325262a0. [DOI] [PubMed] [Google Scholar]
  71. Marchisio Paola, Cavagna Roberta, Maspes Barbara, Gironi Stefania, Esposito Susanna, Lambertini Lara, Massimini Alessandra, Herzog Christian, Principi Nicola. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis. 2002 Jun 19;35(2):168–174. doi: 10.1086/341028. [DOI] [PubMed] [Google Scholar]
  72. Melhus A. Effects of amoxicillin on the expression of cytokines during experimental acute otitis media caused by non-typeable Haemophilus influenzae. J Antimicrob Chemother. 2001 Sep;48(3):397–402. doi: 10.1093/jac/48.3.397. [DOI] [PubMed] [Google Scholar]
  73. Melhus A., Ryan A. F. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect Immun. 2000 Jul;68(7):4024–4031. doi: 10.1128/iai.68.7.4024-4031.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Meyerhoff W. L., Giebink G. S. Panel discussion: pathogenesis of otitis media. Pathology and microbiology of otitis media. Laryngoscope. 1982 Mar;92(3):273–277. doi: 10.1288/00005537-198203000-00010. [DOI] [PubMed] [Google Scholar]
  75. Miller A. J., Gianoli G. J. Eustachian tube dysfunction. J La State Med Soc. 1996 Aug;148(8):329–333. [PubMed] [Google Scholar]
  76. Morpeth J. F., Bent J. P., Watson T. A comparison of cortisporin and ciprofloxacin otic drops as prophylaxis against post-tympanostomy otorrhea. Int J Pediatr Otorhinolaryngol. 2001 Nov 1;61(2):99–104. doi: 10.1016/s0165-5876(01)00552-3. [DOI] [PubMed] [Google Scholar]
  77. Møller P., Dalen H. Middle ear mucosa in cleft palate children. A scanning electron microscopic study. Acta Otolaryngol Suppl. 1979;360:198–203. doi: 10.3109/00016487809123516. [DOI] [PubMed] [Google Scholar]
  78. Nonaka Manabu, Fukumoto Akira, Ozu Chika, Mokuno Eriko, Baba Shunkichi, Pawankar Ruby, Yagi Toshiaki. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol. 2003 Apr;123(3):383–387. doi: 10.1080/0036554021000028117. [DOI] [PubMed] [Google Scholar]
  79. Nutku Esra, Aizawa Hideyuki, Hudson Sherry A., Bochner Bruce S. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood. 2003 Feb 27;101(12):5014–5020. doi: 10.1182/blood-2002-10-3058. [DOI] [PubMed] [Google Scholar]
  80. Närkiö-Mäkelä M., Teppo A. M., Meri S. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion. Laryngoscope. 2000 Oct;110(10 Pt 1):1745–1749. doi: 10.1097/00005537-200010000-00035. [DOI] [PubMed] [Google Scholar]
  81. Ohashi Y., Nakai Y., Tanaka A., Kakinoki Y., Washio Y. Soluble adhesion molecules in middle ear effusions from patients with chronic otitis media with effusion. Clin Otolaryngol Allied Sci. 1998 Jun;23(3):231–234. doi: 10.1046/j.1365-2273.1998.00140.x. [DOI] [PubMed] [Google Scholar]
  82. Okamoto Y., Kudo K., Ishikawa K., Ito E., Togawa K., Saito I., Moro I., Patel J. A., Ogra P. L. Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. J Infect Dis. 1993 Nov;168(5):1277–1281. doi: 10.1093/infdis/168.5.1277. [DOI] [PubMed] [Google Scholar]
  83. Pitkäranta A., Hovi T., Karma P. Interferon production by leukocytes in children with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 1996 Jan;34(1-2):25–33. doi: 10.1016/0165-5876(95)01231-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Pitkäranta A., Jero J., Arruda E., Virolainen A., Hayden F. G. Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion. J Pediatr. 1998 Sep;133(3):390–394. doi: 10.1016/S0022-3476(98)70276-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Poelmans Johan, Tack Jan, Feenstra Louw. Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy. Ann Otol Rhinol Laryngol. 2002 Oct;111(10):933–938. doi: 10.1177/000348940211101013. [DOI] [PubMed] [Google Scholar]
  86. Pollock Hoke W., Ebert Charles S., Dubin Marc G., White David R., Prazma Jiri, Pillsbury Harold C., 3rd The role of soluble interleukin-4 receptor and interleukin-5 antibody in preventing late-phase allergy-induced eustachian tube dysfunction. Otolaryngol Head Neck Surg. 2002 Sep;127(3):169–176. doi: 10.1067/mhn.2002.126901. [DOI] [PubMed] [Google Scholar]
  87. Raveh D., Kruskal B. A., Farland J., Ezekowitz R. A. Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J Leukoc Biol. 1998 Jul;64(1):108–113. [PubMed] [Google Scholar]
  88. Rosenfeld R. M. Nonsurgical management of surgical otitis media with effusion. J Laryngol Otol. 1995 Sep;109(9):811–816. doi: 10.1017/s0022215100131408. [DOI] [PubMed] [Google Scholar]
  89. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890–1893. doi: 10.1073/pnas.89.5.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Rousset F., Peyrol S., Garcia E., Vezzio N., Andujar M., Grimaud J. A., Banchereau J. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int Immunol. 1995 Aug;7(8):1243–1253. doi: 10.1093/intimm/7.8.1243. [DOI] [PubMed] [Google Scholar]
  91. Ruef C., Coleman D. L. Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev Infect Dis. 1990 Jan-Feb;12(1):41–62. doi: 10.1093/clinids/12.1.41. [DOI] [PubMed] [Google Scholar]
  92. Salam M. A., Cable H. R. The use of antibiotic/steroid ear drops to reduce post-operative otorrhoea and blockage of ventilation tubes. A prospective study. J Laryngol Otol. 1993 Mar;107(3):188–189. doi: 10.1017/s0022215100122595. [DOI] [PubMed] [Google Scholar]
  93. Salvi S., Holgate S. T. Could the airway epithelium play an important role in mucosal immunoglobulin A production? Clin Exp Allergy. 1999 Dec;29(12):1597–1605. doi: 10.1046/j.1365-2222.1999.00644.x. [DOI] [PubMed] [Google Scholar]
  94. Sanderson C. J. Eosinophil differentiation factor (interleukin-5). Immunol Ser. 1990;49:231–256. [PubMed] [Google Scholar]
  95. Schousboe L. P., Rasmussen L. M., Ovesen T. RANTES in otitis media with effusion: presence, role and correlation with cytokines and microbiology. APMIS. 2001 Jun;109(6):441–446. doi: 10.1034/j.1600-0463.2001.090606.x. [DOI] [PubMed] [Google Scholar]
  96. Seong Je-Kyung, Koo Ja Seok, Lee Won Jae, Kim Hee-Nam, Park Ji-Young, Song Kyoung Seob, Hong Ji Hun, Yoon Joo-Heon. Upregulation of MUC8 and downregulation of MUC5AC by inflammatory mediators in human nasal polyps and cultured nasal epithelium. Acta Otolaryngol. 2002 Jun;122(4):401–407. doi: 10.1080/00016480260000094. [DOI] [PubMed] [Google Scholar]
  97. Shaw C. B., Obermyer N., Wetmore S. J., Spirou G. A., Farr R. W. Incidence of adenovirus and respiratory syncytial virus in chronic otitis media with effusion using the polymerase chain reaction. Otolaryngol Head Neck Surg. 1995 Sep;113(3):234–241. doi: 10.1016/S0194-5998(95)70111-7. [DOI] [PubMed] [Google Scholar]
  98. Shuto T., Xu H., Wang B., Han J., Kai H., Gu X. X., Murphy T. F., Lim D. J., Li J. D. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci U S A. 2001 Jul 3;98(15):8774–8779. doi: 10.1073/pnas.151236098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Skoner D. P., Stillwagon P. K., Casselbrandt M. L., Tanner E. P., Doyle W. J., Fireman P. Inflammatory mediators in chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg. 1988 Oct;114(10):1131–1133. doi: 10.1001/archotol.1988.01860220065025. [DOI] [PubMed] [Google Scholar]
  100. Skotnicka B., Hassmann E. Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol. 2000;257(6):323–326. doi: 10.1007/s004059900218. [DOI] [PubMed] [Google Scholar]
  101. Sloyer J. L., Jr, Ploussard J. H., Karr L. J. Otitis media in the young infant: an IgE-mediated disease? Ann Otol Rhinol Laryngol Suppl. 1980 May-Jun;89(3 Pt 2):133–137. doi: 10.1177/00034894800890s334. [DOI] [PubMed] [Google Scholar]
  102. Smirnova M. G., Kiselev S. L., Birchall J. P., Pearson J. P. Up-regulation of mucin secretion in HT29-MTX cells by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-6. Eur Cytokine Netw. 2001 Mar;12(1):119–125. [PubMed] [Google Scholar]
  103. Smirnova Marina G., Birchall John P., Pearson Jeffrey P. In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol. 2002 Mar;122(2):146–152. doi: 10.1080/00016480252814144. [DOI] [PubMed] [Google Scholar]
  104. Smirnova Marina G., Kiselev Sergei L., Gnuchev Nickolai V., Birchall John P., Pearson Jeffrey P. Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion. Eur Cytokine Netw. 2002 Apr-Jun;13(2):161–172. [PubMed] [Google Scholar]
  105. Smith K. A. Interleukin-2. Curr Opin Immunol. 1992 Jun;4(3):271–276. doi: 10.1016/0952-7915(92)90076-q. [DOI] [PubMed] [Google Scholar]
  106. Sobol Steven E., Taha Rame, Schloss Melvin D., Mazer Bruce D., Manoukian John J., Tewfik Ted L., Hamid Qutayba. T(H)2 cytokine expression in atopic children with otitis media with effusion. J Allergy Clin Immunol. 2002 Jul;110(1):125–130. doi: 10.1067/mai.2002.125697. [DOI] [PubMed] [Google Scholar]
  107. Somers T., Goovaerts G., Schelfhout L., Peeters S., Govaerts P. J., Offeciers E. Growth factors in tympanic membrane perforations. Am J Otol. 1998 Jul;19(4):428–434. [PubMed] [Google Scholar]
  108. Sone M., Paparella M. M., Schachern P. A., Morizono N., Le C. T., Lin J. Expression of glycoconjugates in human eustachian tubes with otitis media. Laryngoscope. 1998 Oct;108(10):1474–1479. doi: 10.1097/00005537-199810000-00010. [DOI] [PubMed] [Google Scholar]
  109. Spits H., Yssel H., Takebe Y., Arai N., Yokota T., Lee F., Arai K., Banchereau J., de Vries J. E. Recombinant interleukin 4 promotes the growth of human T cells. J Immunol. 1987 Aug 15;139(4):1142–1147. [PubMed] [Google Scholar]
  110. Stenfors L. E., Albiin N., Bloom G. D., Hellström S., Widemar L. Mast cells and middle ear effusion. Am J Otolaryngol. 1985 May-Jun;6(3):217–219. doi: 10.1016/s0196-0709(85)80088-0. [DOI] [PubMed] [Google Scholar]
  111. Stenfors L. E., Räisänen S. Immunoglobulin-coated bacteria in effusions from secretory and chronic suppurative otitis media. Am J Otolaryngol. 1991 May-Jun;12(3):161–164. doi: 10.1016/0196-0709(91)90147-8. [DOI] [PubMed] [Google Scholar]
  112. Stenfors L. E., Räisänen S. Secretory IgA- and IgG-coated bacteria in chronically discharging ears. J Laryngol Otol. 1991 Jul;105(7):515–517. doi: 10.1017/s0022215100116482. [DOI] [PubMed] [Google Scholar]
  113. Sugiura Y., Ohashi Y., Nakai Y. The herbal medicine, sairei-to, prevents endotoxin-induced otitis media with effusion in the guinea pig. Acta Otolaryngol Suppl. 1997;531:21–33. doi: 10.3109/00016489709126133. [DOI] [PubMed] [Google Scholar]
  114. Takada R., Harabuchi Y., Himi T., Kataura A. Antibodies specific to outer membrane antigens of Moraxella catarrhalis in sera and middle ear effusions from children with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 1998 Dec 15;46(3):185–195. doi: 10.1016/s0165-5876(98)00158-x. [DOI] [PubMed] [Google Scholar]
  115. Takasaki K., Sando I., Balaban C. D., Ishijima K. Postnatal development of eustachian tube cartilage. A study of normal and cleft palate cases. Int J Pediatr Otorhinolaryngol. 2000 Jan 30;52(1):31–36. doi: 10.1016/s0165-5876(99)00292-x. [DOI] [PubMed] [Google Scholar]
  116. Takeuchi Kazuhiko, Yagawa Mayuko, Ishinaga Hajime, Kishioka Chikako, Harada Teruhiko, Majima Yuichi. Mucin gene expression in the effusions of otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2003 Jan;67(1):53–58. doi: 10.1016/s0165-5876(02)00361-0. [DOI] [PubMed] [Google Scholar]
  117. Tanaka K., Saito J., Ohashi M., Terayama Y. Histopathology of otitis media with effusion. An electron microscopic study of human temporal bones. Arch Otorhinolaryngol. 1986;243(4):269–273. doi: 10.1007/BF00464444. [DOI] [PubMed] [Google Scholar]
  118. Tasker Andrea, Dettmar Peter W., Panetti Marguerite, Koufman James A., Birchall John P., Pearson Jeffery P. Reflux of gastric juice and glue ear in children. Lancet. 2002 Feb 9;359(9305):493–493. doi: 10.1016/S0140-6736(02)07665-1. [DOI] [PubMed] [Google Scholar]
  119. Tasker Andrea, Dettmar Peter W., Panetti Marguerite, Koufman James A., P Birchall John, Pearson Jeffrey P. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope. 2002 Nov;112(11):1930–1934. doi: 10.1097/00005537-200211000-00004. [DOI] [PubMed] [Google Scholar]
  120. Tos Mirko, Caye-Thomasen Per. Mucous glands in the middle ear - what is known and what is not. ORL J Otorhinolaryngol Relat Spec. 2002 Mar-Apr;64(2):86–94. doi: 10.1159/000057786. [DOI] [PubMed] [Google Scholar]
  121. Trinchieri G., Matsumoto-Kobayashi M., Clark S. C., Seehra J., London L., Perussia B. Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med. 1984 Oct 1;160(4):1147–1169. doi: 10.1084/jem.160.4.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 1988 Jul 21;334(6179):260–262. doi: 10.1038/334260a0. [DOI] [PubMed] [Google Scholar]
  123. Wang P., Wu P., Anthes J. C., Siegel M. I., Egan R. W., Billah M. M. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood. 1994 May 1;83(9):2678–2683. [PubMed] [Google Scholar]
  124. Wertheim W. A., Kunkel S. L., Standiford T. J., Burdick M. D., Becker F. S., Wilke C. A., Gilbert A. R., Strieter R. M. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol. 1993 Aug 15;151(4):2166–2175. [PubMed] [Google Scholar]
  125. Wright E. D., Hurst D., Miotto D., Giguere C., Hamid Q. Increased expression of major basic protein (MBP) and interleukin-5(IL-5) in middle ear biopsy specimens from atopic patients with persistent otitis media with effusion. Otolaryngol Head Neck Surg. 2000 Nov;123(5):533–538. doi: 10.1067/mhn.2000.109472. [DOI] [PubMed] [Google Scholar]
  126. Yamaguchi T., Urasawa T., Kataura A. Secretory immunoglobulin A antibodies to respiratory viruses in middle ear effusion of chronic otitis media with effusion. Ann Otol Rhinol Laryngol. 1984 Jan-Feb;93(1 Pt 1):73–75. doi: 10.1177/000348948409300117. [DOI] [PubMed] [Google Scholar]
  127. Yamanaka N., Somekawa Y., Himi T., Suzuki T., Kataura A. Immune complexes in otitis media with effusion. Auris Nasus Larynx. 1985;12 (Suppl 1):S70–S72. doi: 10.1016/s0385-8146(85)80105-x. [DOI] [PubMed] [Google Scholar]
  128. Yamanaka N., Somekawa Y., Suzuki T., Kataura A. Immunologic and cytologic studies in otitis media with effusion. Acta Otolaryngol. 1987 Nov-Dec;104(5-6):481–486. doi: 10.3109/00016488709128278. [DOI] [PubMed] [Google Scholar]
  129. Yellon R. F., Leonard G., Marucha P. T., Craven R., Carpenter R. J., Lehmann W. B., Burleson J. A., Kreutzer D. L. Characterization of cytokines present in middle ear effusions. Laryngoscope. 1991 Feb;101(2):165–169. doi: 10.1288/00005537-199102000-00011. [DOI] [PubMed] [Google Scholar]
  130. Younis R. T., Lazar R. H., Long T. E. Ventilation tubes and prophylactic antibiotic eardrops. Otolaryngol Head Neck Surg. 1992 Feb;106(2):193–195. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES